Ledger.Open graph →
SEC Form D · filed September 17, 2025

Merge Bio Therapeutics Corp

Offering
$15.0M
Sold
$5.0M
Exemption
Rule 506(b)
Industry
Other
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Wesley Wong · Cambridge, MAExec · Director · PromoterMark Lipstein · Cambridge, MAPromoterSteve Liapis · Emeryville, CADirectorClinton Hansen · Cambridge, MAExec · PromoterElias Quijano · Cambridge, MADirectorDarren Yang · Cambridge, MAPromoterMark Lipstein · Cambridge, MAPromoterSteve Liapis · Emeryville, CADirectorClinton Hansen · Cambridge, MAExec · PromoterElias Quijano · Cambridge, MADirectorWesley Wong · Cambridge, MAExec · Director · PromoterDarren Yang · Cambridge, MAPromoter

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗